Avaí Bio, JV Partner Austrianova Announce First Joint Steering Committee Meeting For Partnership With Ospedale San Raffaele Over Discussion On Initial Research Program To Mull Encapsulated Beta-Cell Replacement Approach For Insulin-Dependent Diabetes

Benzinga · 2d ago

Avaí Bio, Inc. (OTCQB: AVAI) ("Avaí" or the "Company") and its joint venture partner Austrianova, today announced the first joint steering committee meeting for their collaboration with Ospedale San Raffaele S.r.l. (OSR), to discuss the initial research program for evaluating an encapsulated beta-cell replacement approach for insulin-dependent diabetes.